Browse Drug Recalls
6,250 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6,250 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6,250 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 30 mMol 500 mL in 500 mL Intrav... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 40 mMol in 250 mL in 2... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in 100 mL in 15... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 10 mMol in a) 100 mL i... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 9 mMol in 100 mL in 15... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 9 mMol in 50 mL in 50 mL Intrav... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 15 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 30 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 20 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol (14.67 mEq K... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 19, 2017 | Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only.... | Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier | Class II | Fagron Compounding Services LLC dba Fagron Ster... |
| Jun 16, 2017 | Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 15, 2017 | Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL , a.) Single-dose... | Lack of Sterility Assurance | Class II | Hospira a Pfizer Company |
| Jun 15, 2017 | 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq (1 mEq/mL) 4.2 gr... | Lack of Sterility Assurance | Class II | Hospira a Pfizer Company |
| Jun 15, 2017 | Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-d... | Lack of Sterility Assurance | Class II | Hospira a Pfizer Company |
| Jun 15, 2017 | Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4... | Lack of Sterility Assurance | Class II | Hospira a Pfizer Company |
| Jun 1, 2017 | methylcobalamin 1mg/1mL, vial for injection, Rx only, MedPark Pharmacy 2002 ... | Lack of Assurance of Sterility | Class II | MedPark Pharmacy, LLC |
| May 18, 2017 | ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volum... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volum... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentrat... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml, Total Vo... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 100mL 0.9% Sodium Chloride injectable,20 mcg per mL,... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectable, 4g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 15, 2017 | Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intrav... | Lack of assurance of sterility: customer complaints received for the presence of leaks. | Class II | Baxter Healthcare Corporation |
| May 15, 2017 | Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose ... | Lack of assurance of sterility: customer complaints received for the presence of leaks. | Class II | Baxter Healthcare Corporation |
| Apr 18, 2017 | FERR GLUC/PROCAINE 10ML MDV 60/10MG/ML INJ, Injection, 60mg/10mg/mL, Rx only,... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 5ML PBF MDV (CALIF) 10MG/ML INJ, Injection, 10mg/mL, RX only, 5mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 11.8/17.6/0.59 5ML MDV MCG/MG/MG/ML INJ, Injection, 11.8mcg/17.6mg/0.... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 45.45/27.27/0.45 5ML MDV MCG/MG/MG/ML INJ, Injection, 45.45mcg/27.27m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | 5-MTHF *10ML* MDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10mL Glass/Multiple... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ, Injection, 25mg/mL, Rx only, 20mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 20/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/0.5mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Mul... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 30ML PBF MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 30 m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | QUAD MIX 1/30/0.5/0.1 5ML MDV MCG/MG/MG/MG/ML INJ, Injection, 1mcg/30mg/0.5mg... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 *1ML* SDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 1 mL Glass/Sing... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | IRON SPECIAL 5ML MDV 60/10MG/5MCG/ML INJ, Injection, 60mg/1mg/5mcg/mL, Rx onl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | DMSO 6.25% OPHTH., 6.25%, Rx only, 15 mL plastic/Multiple Dose bottle, Prepar... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CYANOCOBALAMIN 10ML MDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 10mL Glass/Mu... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.